| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.7M | -0.5% |
| Cost of Revenue | $20.5M | -11.3% |
| Gross Profit | -$7.8M | +24.6% |
| R&D Expense | $11K | -90.1% |
| SG&A Expense | $5.6M | -2.9% |
| Operating Income | -$16.2M | +18.1% |
| Pre-tax Income | -$17.1M | +13.8% |
| Income Tax | $2K | -98.5% |
| Net Income | -$17.1M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.4M | -78.1% |
| Accounts Receivable | $288K | +179.0% |
| Inventory | $4.9M | -72.1% |
| Current Assets | $8.2M | -67.9% |
| Total Assets | $11.5M | -60.9% |
| Current Liabilities | $1.6M | -9.5% |
| Total Liabilities | $4.9M | -19.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.4M | -12.2% |
| Capital Expenditures | $9K | -94.3% |
| Investing Cash Flow | -$9K | +94.3% |
| Financing Cash Flow | $2.8M | +0.0% |
| Free Cash Flow | -$5.4M | -8.9% |
| +14.3% |
| EPS (Basic) | -$2.47 | +24.5% |
| Stockholders' Equity |
| $6.6M |
| -71.8% |